Record-High Quarterly Revenues, Up 347.8% YoY Achieved Quarterly Adjusted Operating Income2 (non-GAAP) and the Second Consecutive Quarter of Adjusted Net […]
RESEARCH TRIANGLE PARK, N.C., Nov. 18, 2024 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Health Services Executive […]